MONCTON, NEW BRUNSWICK--(Marketwired - July 21, 2015) - A correction from source is being issued by OrganiGram Holdings Inc. for the release disseminated on July 21st at 2:16 PM ET. A reference in the second paragraph to MFT has been amended to "the principals of MFT." The complete and corrected release follows.

OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQX:OGRMF) (the "Company") wishes to issue the following statement regarding this morning's announcement of a lawsuit filed against OrganiGram Holdings and OrganiGram Inc. by Marijuana for Trauma (MFT).

"While we are aware of the lawsuit filed by MFT, the details, as outlined in their national press release are inaccurate and defamatory. At no time was there ever an agreement with Organigram Holdings or OrganiGram Inc. with MFT in relation to the development of Trauma Healing Centers (THC) across the country. As well, we believe this lawsuit to be an attempt to embarrass the principals and the company as well as to deflect from the failure of the principals of MFT to fulfill an employment contract they signed with THC in 2014. We intend to defend these false claims vigorously in court and intend to file a counter claim against MFT. As well, this lawsuit has given us the opportunity to fully understand that MFT has not been operating openly and honestly. As a result of their news release we have discovered that MFT has been signing exclusive deals with a number of licensed medical marijuana producers (LPs) across the country and not fulfilling those contractual obligations. At the end of the day we look forward to the truth being unveiled."

About OrganiGram Holdings

Organigram Holdings Inc. is a TSX Venture Exchange listed company who's wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. At OrganiGram, our mission is to be the leading producer of organically grown medical marijuana. By combining advanced technologies and proven methods, we assure a secure and regulated source of medical marijuana for patients and doctors in Canada that requires no irradiation or cold pasteurization. All of our products are lab tested prior to packaging and are manufactured under strict controls and in conformance with the Good Production Practices of the MMPR as well as the security directives as defined by the Office of Controlled Substances - See more at:

Contact Information:

To arrange an interview, please contact:
OrganiGram Holdings Inc.
Brett Allan
Director of Investor Relations & Business Development